ArticleMethods in molecular biology (Clifton, N.J.)2026
In Vivo Preclinical Platforms to Study Coronavirus Infection.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 has increased the attention to viral diseases due to the global rapid dissemination, high transmissibility, and potential lethality. In these situations, the development of pre-clinical models is crucial to better understand the molecular aspects of the pathogenesis of such condition. Thus, animal models of Betacoronavirus infection that mimic disease features observed during COVID-19 in humans are fundamental tools to uncover disease mechanisms. In this chapter, we describe in detail the animal models and the pathogenesis of the disease caused by different Betacoronaviruses in rodents. The main differences between the murine models used for coronavirus studies are discussed, such as the mouse model for mouse hepatitis virus (MHV) infection as well as humanized model (K18-hACE2), as well as hamster models for infection with SARS-CoV-2. Methods concerning virus manipulation and animal infection are also described in detail, along with important notes on different techniques to assess clinical outcomes and protocols of sample collection for further biochemical, immune, microbiological and histopathological examination.
Indexed as
Identifiers
41478943What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.